| Released | Contributor | Author | Title | Pages | Price |
| 29-Nov-2009 | PriceTarget Research, Inc. |
N/A
| IMA has a current Overall Rating of A (Highest Rating). | 7 |
$25 |
| 26-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for MEDICAL SUPPLIES | 18 |
$49 |
| 26-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: INVERNESS MED -- IMA | 1 |
$4 |
| 26-Nov-2009 | New Constructs, LLC |
N/A
| IMA: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings | 19 |
$10 |
| 26-Nov-2009 | Pechala's Reports | Lubomir Pechala | INVERNESS MEDICAL INNOVATIONS INC (IMA=US) - REPORT FOR ACTIVE TRADERS | 4 |
$25 |
| 24-Nov-2009 | Jefferson Research |
N/A
| Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of INVERNESS MEDICAL INNOVATNS including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. | 3 |
$20 |
| 23-Nov-2009 | Zacks Investment Research Inc. |
N/A
| INVERNESS MEDCL (IMA) Zacks Company Snapshot | 1 |
$10 |
| 23-Nov-2009 | Reuters Investment Profile |
N/A
| Inverness Medical Innovations Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 |
$20 |
| 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Plunkett's Health Care Technologies Overview 2010 (Summary) | 80 |
$199 |
| 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Health Care Industry Market Research and Competitive Analysis 2010 | 730 |
$299 |
1.48% Nasdaq 
Research Reports
